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METHODOLOGY ARTICLE Open Access
A haplotype-based normalization technique
for the analysis and detection of allele
specific expression
Alan Hodgkinson1,3*, Jean-Christophe Grenier1, Elias Gbeha1,2,4 and Philip Awadalla1,2,4
Abstract
Background: Allele specific expression (ASE) has become an important phenotype, being utilized for the
detection of cis-regulatory variation, nonsense mediated decay and imprinting in the personal genome, and has
been used to both identify disease loci and consider the penetrance of damaging alleles. The detection of ASE
using high throughput technologies relies on aligning short-read sequencing data, a process that has inherent
biases, and there is still a need to develop fast and accurate methods to detect ASE given the unprecedented
growth of sequencing information in big data projects.
Results: Here, we present a new approach to normalize RNA sequencing data in order to call ASE events with
high precision in a short time-frame. Using simulated datasets we find that our approach dramatically improves
reference allele quantification at heterozygous sites versus default mapping methods and also performs well
compared to existing techniques for ASE detection, such as filtering methods and mapping to parental genomes,
without the need for complex and time consuming manipulation. Finally, by sequencing the exomes and
transcriptomes of 96 well-phenotyped individuals of the CARTaGENE cohort, we characterise the levels of ASE
across individuals and find a significant association between the proportion of sites undergoing ASE within the
genome and smoking.
Conclusions: The correct treatment and analysis of RNA sequencing data is vital to control for mapping biases
and detect genuine ASE signals. By normalising RNA sequencing information after mapping, we show that this
approach can be used to identify biologically relevant signals in personal genomes.
Keywords: Allele specific expression, RNA sequencing, Normalization
Background
Allele specific expression (ASE) is a phenomenon by
which the expression of the two parental alleles is unbal-
anced. Over the past decade, the rise of high-throughput
sequencing has facilitated the detection of ASE via RNA
sequencing data [1–4], allowing for the detection of sig-
nals associated with cis-regulatory variation, loss of func-
tion alleles, imprinting and other important biological
phenomenon [5–10]. ASE has also been implicated in
human disease, either as a signal of variable gene expres-
sion or via the impact on the penetrance of damaging al-
leles [7, 11]. However, despite its potential use as a key
indicator of biological processes, genuine ASE events
can be difficult to detect without bias. Existing experi-
mental approaches such as genotyping arrays or padlock
probes still face many challenges [2], and although RNA
sequencing can be used to identify events transcriptome
wide, many factors can influence the detection of ASE
from RNA sequencing data, including both technical
and mapping issues [12, 13], which need to be corrected
before reliable biological conclusions can be drawn. Per-
haps the most accessible of these is sequence mapping
biases, particularly since correction methods can be used
to improve signals within the plethora of pre-existing
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datasets rather than requiring complete experimental re-
design.
In order to detect ASE events from RNA sequencing
data, a binomial test is often implemented to detect
significant differences from the expected 50:50 ratio of
alleles. This approach can be limited by coverage and
power constraints, and consequently more advanced
techniques are being developed [14, 15]. Prior to this, all
current approaches rely on sequence read alignment and
some form of correction procedure. Pre-existing map-
ping correction methods mostly fall into two camps:
filtering potentially problematic sites [9, 13] and map-
ping separately to each parental genome [16–18], which
is similar in concept to recoding the reference genome
with standard ambiguous nucleotide codes prior to map-
ping [1]. The former approach is appealing since it is
relatively simple to implement, however it runs the risk
of removing problem areas of the genome that could still
show biologically relevant signals if handled properly,
and also potentially over-generalises effects by relying
heavily on known biases and common SNPs in the
genome, missing personal genome effects. Mapping to
parental genomes, although appearing to be more accur-
ate [16], requires not only assumptions about phasing
and SNP calling from parental genomes, but also a large
amount of complex manipulation and processing time;
something not readily applicable to large high-throughput
analysis and big data projects. Here, we propose a new ap-
proach that normalizes mapped RNA sequencing data by
generating an assumed null dataset that can be used for
correction of real data. We find that this approach leads
to an improvement in reference allele quantification
across a number of different mapping strategies and
also compares favourably in either performance or pro-
cessing time to alternative techniques when calling in-
stances of ASE.
Results and discussion
Typical identification of ASE from RNA sequencing data
involves considering the ratio of reference and alternative
alleles within sequencing reads that overlap heterozygous
single nucleotide variants (SNVs), identifying sites that
deviate significantly from the expected 50:50 ratio. How-
ever, mapping biases can lead to observed allele ratios in
sequencing data that do not reflect the underlying bio-
logical state.
In order to account for these biases we apply the fol-
lowing general approach (for more details see methods
and Additional File 1): First, we map an RNA sequen-
cing dataset to a reference genome. Second, we map
corresponding exome sequencing data and call SNVs
and indels. In practice, genomic SNVs and Indels can
be obtained from DNA via any technology and coded in
VCF format. Third, we generate a null high coverage
RNA sequencing dataset that contains all SNVs and
indels uncovered from the exome data, present at exact
50:50 ratios for the two parental alleles at all heterozy-
gous sites. To do this, we sample read pairs from the
original mapped RNA dataset and then recreate the
two parental haplotypes in each case, repeating the
process with replacement to generate a high coverage
null dataset. Since the genetic background of variants is
only important within reads for the simulation, variants
do not need to be pre-phased. Fourth, we map the null
sequencing dataset using the same software/pipeline as
used in step one. In this way, any biases in the mapping
procedure can be uncovered. Finally, we use the map-
ping biases observed in the mapped null dataset to
normalize the original data (Fig. 1). A software package
to generate a null high coverage dataset and to analyse
results after mapping is available at https://github.com/
AJHodgkinson/ASE.
Simulations
To test the performance of our normalization ap-
proach, we generated simulated RNA sequencing data
with gene expression levels and parental allelic ratios at
heterozygous sites that matched real data. We then
mapped these data using two commonly used aligners,
Tophat2 [19] and STAR [20], the latter of which is the
current gold-standard mapping tool suggested in the
GATK [21] pipeline. In each case, we also varied some
of the parameters used for mapping to consider which
approach was most accurate. For Tophat2 we used both
the default parameters (which, among other parame-
ters, allows for a maximum of 2 mismatches per read),
and also allowed for 5 mismatches per read, which is
consistent with the default values used in other
aligners. For STAR, we mapped the data using the de-
fault parameters and also after disabling soft-clipping of
reads. For each simulation, the proportion of reads con-
taining the reference allele at each heterozygous site
was varied, generating a unique RNA sequencing data-
set in each case and allowing for the full spectrum of
biases to be explored.
For each of the four mapping approaches, we gener-
ated five independent simulated datasets, mapped
reads to the reference genome and compared observed
parental allele proportions at heterozygous sites to the
ground truth. Mapping with STAR after disabling soft
clipping performed best (sum of squared differences
between mapped and ground truth for proportion of ref-
erence alleles at heterozygous sites (SSE) = 16.04, R2 =
0.954 for correlation of data points), followed by default
mapping with STAR (R2 = 0.943, SSE = 24.48), mapping
with Tophat2 and allowing for 5 mismatches per read
(R2 = 0.912, SSE = 32.01) and then default mapping with
Tophat2 (R2 = 0.677, SSE = 191.3) (Fig. 2a). Importantly,
Hodgkinson et al. BMC Bioinformatics  (2016) 17:364 Page 2 of 10
the accuracy was significantly improved after applying our
normalization approach in all cases (Wilcoxon signed-
rank test to compare mean standard errors: STAR with no
softclipping p < 2.2e−16, R2 = 0.974, SSE = 8.73; STAR
default: p < 2.2 × 10−16, R2 = 0.954, SSE = 16.22; Tophat2
with 5 mismatches: p < 2.2 × 10−16, R2 = 0.949, SSE =
17.57; Tophat2 default: p < 2.2 × 10−16, R2 = 0.851, SSE
= 57.27) (Fig. 2b). To explore further whether the num-
ber of mismatches allowed influenced our ability to detect
the correct proportion of reference alleles in different
regions of the genome for each software, we repeated our
analysis above and performed a parameter sweep from 1
a b
Fig. 1 a Schematic for the normalization procedure. For a given heterozygous SNV the underlying proportion of reference and alternative alleles
is unknown. After mapping, the proportion of reference/alternative alleles is observed, but may contain biases. To correct for this, a null dataset is
generated for this site containing a 50:50 ratio of the two alleles (see panel b), and this data, together with null data from all other heterozygous
sites is mapped using the same procedure as used for the original alignment. The observed proportion of mapped alleles from the null dataset
is then used to correct the original data. b Generation of the null dataset. All reads and read pairs covering a heterozygous SNV are shown in
the left hand panel. From these data, read pairs are randomly selected and the second haplotype is generated from known SNV data for the
individual. In the right hand panel, three examples of this process are shown. At the top, the original read pair contains the reference allele at the
SNV of interest (C/T), as well as the reference allele at a neighbouring SNV (G/A). The second haplotype is thus generated with the alternative
alleles at both positions. In the middle, the original read pair contains two alternative alleles at the SNV sites, so an alternative read pair is
generated with both reference alleles. At the bottom, the read pair contains the reference allele at the central SNV site, and what appears to be a
sequencing error upstream at a site where no SNV has been identified. As such, a read pair is created with the sequencing error unchanged, and
the alternative allele at the SNV position. This process is repeated for all read pairs to generate a null dataset with coverage of 4000X, and reads
are converted into fastq format for remapping
Fig. 2 The proportion of reference alleles at heterozygous sites before and after normalization. Each plot shows the combined results from five
simulated datasets, with the known reference proportion (ground truth) on the x-axis and the reference proportion obtained from aligning sequencing
data (estimated) on the y-axis. a Shows the results obtained from initial mapping under four different approaches, and (b) shows the results of the
same approaches after normalization. The sum of squared errors (SSE) is calculated around the red line (x = y), whereas R2 is obtained from analysing
the correlation between the two variables
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to 10 mismatches allowed on average per read for
Tophat2, STAR and STAR (with soft clipping disabled)
using one of our simulated datasets. In stable regions of
the genome (those with 2 or fewer heterozygous SNVs per
MB) we find that generally there is a good match between
the proportion of reference alleles detected across all het-
erozygous sites compared to the ground truth when 3 or
more mismatches are allowed per read (R2 > 0.9 for all
software, see Additional File 2: Figures S1, 2 and 3). For
these regions our normalization approach had a similar
performance to mapping reads without correction. For
highly variable regions (those in the top 2.5 % of MBs,
>30 heterozygous SNVs per MB), the correlation be-
tween mapped data and the ground truth for the pro-
portion of reference alleles at heterozygous sites was
much weaker (as low as R2 = 0.18 for Tophat2 allowing
1 mismatch per read, more generally R2 ~ 0.8 for 3 or
more mismatches allowed per read), yet in this case our
normalization approach greatly improved the strength
of correlations (3 mismatches or greater, R2 ~ 0.9 for all
software, see Additional File 2: Figures S1, 2 and 3).
Following this we considered how well ASE events
were called in both the original mapping data for the
four approaches outlined above, as well as after
normalization in each case, by comparing calls to the
underlying truth in simulated datasets. To do this we
considered only heterozygous sites covered by at least
12 sequencing reads (overlapping pairs counted once) and
used a binomial test with P < 0.005 to define a site as
undergoing ASE. On average across each of the five simu-
lated datasets, STAR with no soft clipping (sensitivity =
82.66 %, specificity = 99.56 %, precision = 74.61 %) and
Tophat2 with 5 mismatches (sensitivity = 81.78 %, specifi-
city = 99.57 %, precision = 74.72 %) performed best,
followed by default STAR mapping (sensitivity = 71.40 %,
specificity = 99.25, precision = 59.87 %) and then default
Tophat2 mapping (sensitivity = 59.15 %, specificity =
96.14 %, precision = 19.32 %) (Table 1). Again, our
normalization approach improved the precision of calling
ASE events in all cases (Table 1). Overall, mapping with
Tophat2 (5 mismatches) and applying our normalization
method gave the best precision of 88.03 % (vs 83.50 %
after normalization, mapping with STAR and no soft
clipping). Applying our normalization approach to data
mapped with STAR (with no soft clipping) resulted in the
best sensitivity (82.91 %), although this was only margin-
ally better than after normalising mapping data from
Tophat2 (5 mismatches), which was 80.97 %.
Next, we generated an additional 20 simulated RNA se-
quencing datasets (making a total of 25) and compared
our normalization method to both a site filtering approach
and mapping to both parental genomes in order to detect
ASE events. In each case we mapped with both Tophat2
(with 5 mismatches) and STAR (disabling soft-clipping),
given that these approaches performed best during testing
on a smaller number of simulated datasets (above). On
average, each simulated dataset contained 179.4 genuine
ASE events. Using STAR (no soft clipping) mapping and
applying our normalization method, 147.4 true positives
and 29.0 false positives were detected, leading to sensitiv-
ity of 82.28 %, specificity of 99.75 % and precision of
83.52 %. Mapping to both parental genomes performed
marginally better overall with sensitivity, specificity
and precision of 84.80 %, 99.81 % and 87.17 % re-
spectively, whereas the filtering method performed
worse (sensitivity = 68.53 %, specificity = 99.63 %, pre-
cision = 73.70 %) (Table 2). Mapping with Tophat2
(5 mismatches) and applying our normalization ap-
proach allowed for the detection of 142.28 true ASE
events and 19.80 false positives, leading to sensitivity,
specificity and precision of 79.42 %, 99.83 % and
87.69 % respectively. In this case, both the filtering
method and mapping to two genomes had a lower preci-
sion (Table 2). Overall, mapping with Tophat2 (5 mis-
matches) and applying our normalization method leads to
the best precision.
RNA sequencing data
We sequenced the whole exomes and transcriptomes of
96 individuals from whole blood, called SNVs and indels
Table 1 A comparison of ASE call rates for original mapped data and after normalization, for four different alignment methods
Method True Positives False Positives True Negatives False Negatives Sensitivity Specificity Precision
Tophat2 108.2 452.4 11281.0 74.6 59.15 % 96.14 % 19.32 %
Tophat2 Normalized 110.4 94.0 11639.4 72.4 60.33 % 99.20 % 53.90 %
STAR 130.8 87.6 11666.8 52.4 71.40 % 99.25 % 58.87 %
STAR Normalized 135.2 40.2 11714.2 48.0 73.75 % 99.66 % 77.03 %
TH2_5MM 149.6 50.6 11702.8 33.4 81.78 % 99.57 % 74.72 %
TH2_5MM Normalized 148.2 20.0 11733.4 34.8 80.97 % 99.83 % 88.03 %
STAR (No clip) 151.6 51.4 11703.0 31.6 82.66 % 99.56 % 74.61 %
STAR (No clip) Normalized 152.0 30.0 11724.4 31.2 82.91 % 99.74 % 83.50 %
In all cases, the true number of significant ASE events averaged across five simulations is 183.2
Hodgkinson et al. BMC Bioinformatics  (2016) 17:364 Page 4 of 10
from the exome and RNA data and mapped and filtered
RNA sequencing reads with both Tophat2 and STAR,
before applying our normalization method to detect
ASE events (removing three outlier individuals, see
methods). Final results obtained were quantitatively
similar (Additional File 3 Table S2) for both mapping
procedures, so from this point on we discuss the results
obtained from Tophat2 mappings. After initial sequence
alignment, each individual had an average of 9895 hetero-
zygous sites covered by at least 12 sequencing reads
(counting overlapping fragments only once). Of these, an
average of 726.6 ASE events were identified per individ-
ual, representing 7.34 % of sites, although clearly this
value is highly dependent on the coverage threshold
used. After remapping the data to tolerate a higher
number of mismatches (as above) and applying our
normalization approach, 10017 sites were covered by at
least 12 non-overlapping reads (reflecting the improved
mapping procedure) and 550.1 of these sites were iden-
tified as undergoing ASE, which is consistent with the
removal of false positives as highlighted during the ana-
lysis of simulated data.
To confirm the reliability of the data we hypothesised
that adjacent heterozygous SNVs in each gene should have
similar parental allelic proportions in genes predicted to
have only one transcript (genes with multiple transcripts
may be undergoing isoform specific expression [9]). Con-
sistent with this we found that our normalization ap-
proach and altered mapping parameters significantly
reduce allelic differences at adjacent sites compared to
original mapped data (5.06 % on average, vs 5.89 % for
original mapped data, p = 1.15 × 10−57). Furthermore, we
found that our normalized dataset had an average refer-
ence allele proportion closer to the expected 50 % for 93
out of the 93 individuals, compared to original mapped
data, and that the mean proportion of reference alleles at
heterozygous sites was not significantly different from
50 % for 70 individuals after normalization (p < 0.05 after
Bonferroni correction).
Finally, in order to consider the biological context of
allele specific expression, we compared the proportion
of sites undergoing ASE in each individual with five life-
style traits (smoking, sun exposure, fruit and vegetable
intake, levels of sleep and alcohol intake), adjusting for
age, sample site and blood cell counts. Since it is more
likely that ASE events are detectable at higher coverage
[22], in order to compare across individuals, we
resampled each heterozygous site without replacement
to a depth of 20X, and relaxed our threshold for detect-
ing ASE events to P < 0.05. On average, each individual
had 8822 sites covered by at least 20 RNA sequencing
reads and of these, 207.3 showed significant evidence of
ASE after normalization (range 157–271, Fig. 3a). Com-
paring these values to lifestyle traits across individuals,
we found no significant associations for four of the
traits (p > 0.05 in all cases), however we observe that
the proportion of sites undergoing ASE in whole blood
data is significantly associated with smoking (full model
p = 2.85 × 10−4, Bonferroni corrected = 1.4 × 10−3, cor-
relation p-value = 9.2 × 10−7, Fig. 3b). It is worth noting
that using the original mapped data the relationship be-
tween these two variables is not significant (P = 0.411),
reinforcing the need for the correct treatment of data
for ASE analysis when attempting to uncover biologically
relevant signals.
Conclusions
The use of high-throughput sequencing to detect ASE is
becoming increasingly common. The technique allows
for the identification of biologically relevant signals at
the level of the individual, many of which may have im-
portant implications for our understanding of human
disease. However, the mapping of short read sequences
has inherent biases, and as data sets grow to unprece-
dented scales, it is becoming increasingly important to
develop fast and reliable methods to identify genuine ASE
events.
By applying a new approach for the normalization of
RNA sequencing data to simulated data sets, we high-
light two important results. First, selection and fine-
tuning of sequencing alignment methods can drastically
improve ASE analysis, reducing false positives and im-
proving signal detection. The use of higher thresholds
for mismatch tolerance, sensible read clipping and
rigorous filtering of ambiguously placed reads leads to
improved results. Second, our normalization approach
Table 2 A comparison of ASE call rates for three different approaches: a filtering methods, mapping to two parental genomes and
our normalization approach
Mapping procedure Control Method True Positives False Positives True Negatives False Negatives Sensitivity Specificity Precision
TH2_5MM Normalized 142.28 19.80 11737.80 36.80 79.42 % 99.83 % 87.69 %
TH2_5MM Two Genomes 144.96 21.84 11737.68 34.44 80.84 % 99.81 % 86.85 %
TH2_5MM Filtered 117.44 46.12 11711.48 61.64 65.71 % 99.61 % 71.77 %
STAR (No clip) Normalized 147.40 29.00 11729.24 31.80 82.28 % 99.75 % 83.52 %
STAR (No clip) Two Genomes 152.24 22.28 11724.96 27.16 84.80 % 99.81 % 87.17 %
STAR (No clip) Filtered 122.68 43.72 11714.52 56.52 68.53 % 99.63 % 73.70 %
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can be used to further improve the detection of ASE.
Our approach performs better than general site filtering
techniques, which while simple and quick to imple-
ment, often do not take into account the personal na-
ture of genomes and can also over-filter biologically
relevant signals. Our approach also performs broadly
similar to mapping to two parental genomes (with
greater precision, but lower sensitivity), but with far
less complex manipulation of data on a per sample
basis. In our hands, once the original data is aligned, it
can be normalized using SNVs and indels from exome
sequencing data in ~120 min per sample with STAR
and ~210 min with Tophat2 (including null data
generation, mapping and filtering of null data and
normalization, using a single node, with two 2.667GHz
six-core processors, ~65 million read pairs), thus allow-
ing this approach to be applied in large-scale sequen-
cing studies.
Applying our approach to RNA sequencing data from
96 individuals we find evidence that suggests a low
error rate in calling the ratio of parental alleles at het-
erozygous sites. First, we find consistency in parental
allele biases within genes with single isoforms, suggest-
ing consistent patterns of expression. Second, we find
that the data conforms more readily to expectations
that on average parental alleles should show a 50:50 ra-
tio of expression. Finally, we identify a relationship be-
tween the total proportion of ASE events per individual
and smoking using RNA sequencing data from whole
blood. Although many previous studies have identified
variation in gene expression profiles between smokers
and non-smokers [23–26], we demonstrate here a non-
specific, genome-wide influence of smoking on the
biased expression of alleles at heterozygous sites in
whole blood data. This serves as an example of how
carefully treated analysis of RNA sequencing data for
ASE detection can be used to identify biologically rele-
vant signals.
Methods
Study population and phenotypic data
The study was approved by the Ethical Review Board
Committee of Sainte-Justine Research Center and in-
formed consent was obtained from all participants. 96
male individuals were drawn from the CARTaGENE
biobank [27] for exome and RNA sequencing. Whole
blood samples were collected in EDTA tubes (for DNA)
and in Tempus tubes (Life Technologies) for RNA
work. All samples were stored at -80C until processing.
Lifestyle phenotypes were obtained from CARTaGENE’s
self administered module. Alcohol intake was split into
six groups based on frequency of intake (never, less
than once per month, monthly, 2/3 per month, 2/3 per
week, everyday/almost everyday), sun exposure into six
groups (time spent in sun during summer between
11 am-4 pm on weekdays, groups ranged from <30mins
per week to 5–6 h per week), fruit and vegetable intake
into four categories, sleep was sorted by average num-
ber of hours slept per night and smoking level was
sorted into two groups of current regular (daily)
smokers and current non-smokers (never smoked, past
smoker, occassional smoker).
DNA and RNA preparation and sequencing
Full details of preparation and sequencing procedures
have been previously documented [28, 29]. In brief, total
RNA was extracted using the Tempus Spin RNA isola-
tion kit (Life Technologies) and globin mRNA-depletion
performed with the GLOBINclear-Human kit (Life
Technologies). A 2100 Bioanalyzer instrument (Agilent)
was used to check the quantity and integrity of RNA
and all samples in our study had an RNA Integrity
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Number (RIN) > 7.5. Paired-end RNASeq libraries were
constructed using the TruSeq RNA Sample Prep kit v2
(Illumina) and 500 ng of globin mRNA-depleted total
RNA. Quality control and quantification of RNA sequen-
cing libraries were performed prior to sequencing using
Illumina’s recommended protocols. 100 bp paired-end
RNA sequencing was performed on the Illumina HiSeq
2000 platform, using three samples per sequencing lane,
at the Genome Quebec Innovation Centre, Montreal,
Canada. Exome paired-end library construction was per-
formed using the TruSeq Exome Enrichment and TruSeq
DNA LT Sample Prep v2 kits (Illumina) before 100 bp
paired-end sequencing using six samples per sequencing
lane on the HiSeq 2000 platform.
Alignment and variant calling
Exome sequencing read ends were trimmed for adaptor
sequences and nucleotides that had a phred-quality
score <20 and data were mapped to a reference genome
(hg19, European Hapmap (CEU) major allele release)
with bwa-aln using default parameters [30]. PCR dupli-
cates were removed with Picard-tools, properly paired
reads were kept with samtools v1.1 [31] and non-
uniquely mapped reads filtered. Local realignment and
base score recalibration was performed using GATK
tools v3.2-2 [21]. On average, we achieved a coverage of
~40X. Single nucleotide variants (SNVs) and Indels
were called with GATK tools by first using the haplo-
type caller per individual, then genotype calling across
samples and finally VQRS filtering of low quality SNVs
and Indels. Variants were then filtering to keep sites
with coverage > =10 and those in Hardy-Weinburg
equilibrium (p > 0.001). Any SNVs falling within indels
were removed.
RNA sequencing reads for the same samples were
trimmed as above and then mapped to a reference gen-
ome (hg19, European Hapmap (CEU) major allele release)
with two commonly used aligners, Tophat2 [19] and
STAR [20], using the Ensembl gene set (v75). For Tophat2
we mapped using both the default parameters and also
allowing for five mismatches per read. For STAR we im-
plemented two-stage mapping with the default parameters
and also while disabling softclipping (using –alignEnd-
sType EndtoEnd). Reads were then filtered as above. SNV
and Indel calling were performed for RNA sequencing
data using GATK tools v3.3. The –SplitNCigarReads op-
tion was used prior to base score recalibration, haplotype
calling using variants from dbSNP v128 and merging of
the 96 gVCF files. After calling, hard filtering was applied
with parameters –cluster 3, FS > 30, QD < 2 and cover-
age > 10. After SNV and indel calling, one individual
was removed as an outlier in terms of the number of
heterozygous SNVs. Since all samples were from males,
for all analyses we focus on the autosomes.
Normalization method
After mapping and filtering we generated a high cover-
age “null” dataset for correction of the original RNA
sequencing data using the following method. Using the
mapped RNA sequencing data, read and read pairs cov-
ering the first heterozygous SNV site (as identified from
exome sequencing) were identified using samtools (RNA
SNV/Indel calls were also included for real data). Then,
each read pair covering that site was extracted and cop-
ied, generating two identical synthetic read pairs in each
case. One of these pairs was then scanned for the presence
of heterozygous SNVs/Indels using exome sequencing
calls – if a variant was found, the read was modified to
contain the opposite parental allele. This was repeated for
all variants within the read pair (tallying the number of
SNVs modified for each pair and storing this as the
SNPweight of the read pair), and then for all reads cover-
ing the heterozygous site, ultimately creating two sets of
read pairs, each of which represented one of the two
parental haplotypes. Sets of read pairs containing each
parental haplotype were then grouped together and sam-
pled randomly with replacement to generate coverage
of 4000X. During this process, sets were kept with
probability 1/SNPweight to ensure that even coverage
was obtained across neighbouring heterozygous sites.
The process was then repeated across all heterozygous
SNVs, and reads were combined and converted to fastq
format, thus generating a null dataset where parental
haplotypes were present at exact 50:50 ratios across the
entire transcriptome.
Null Fastq files were then remapped onto the genome
using exactly the same approach as the original RNA
sequencing data. In this way, since all alleles present at
heterozygous sites were present at exact 50:50 ratios,
any biases in the mapping process could be identified.
After mapping of the null data, allele counts were ob-
tained at each heterozygous site using a custom script,
and used to normalize the original RNA sequencing data
using the following formula:
Aref ¼ Nullref −Sref
! "
Scov
" Ocov
# $
þ Oref
Where Aref = adjusted reference allele count, Nullref =
number of reference alleles in null data, Sref = observed
reference allele count in null data, Oref = observed refer-
ence allele count in real data, Scov = sampled coverage at
site in null data, Ocov = observed coverage at site in real
data. Aref represents the adjusted number of reference al-
leles after correction using the null data, which is then
rounded to the nearest whole number to be compatible
with a binomial test. A similar calculation was per-
formed for the alternative allele, and then combined
with the above to get the adjusted coverage.
Hodgkinson et al. BMC Bioinformatics  (2016) 17:364 Page 7 of 10
Simulations
In order to test the performance of our approach, we gen-
erated a simulated transcriptome that contained variants
present in one of our sequenced samples, with parental al-
leles at known proportions that mirror the real data.
SNV and Indel calls generated from exome sequencing
data were phased with ShapeIT2 [32], using read-aware
phasing across the 96 samples. French-Canadian recom-
bination maps were obtained from Hussin et al. [29] and
data was split into chromosomes for phasing, except for
chromosome 1, which was split into arms at the centro-
mere. Trimmed RNA sequencing data for a single sam-
ple was mapped to a reference genome (hg19, European
Hapmap (CEU) major allele release, Ensembl gene set)
with RSEM [33], generating expression levels for each
transcript. The option rsem-simulate-reads was then
used to generate simulated RNA sequencing data, with
input parameters generated from the original mapping
results. Since the simulated dataset contained no SNVs
or Indels, we used a custom script to insert phased vari-
ants obtained from exome sequencing data for the same
individual into the simulated sequencing reads. During
this step, to generate a range of parental allele ratios to
insert into simulated data we calculated the proportions
of reference alleles at each heterozygous site in the real
RNA sequencing data for the same individual (where
coverage was >8X), which was then centred at 50 % (by
adding 1-x to the distribution for each site, where x is
the proportion of reference alleles at that heterozygous
site. For the final reference allele distribution, see
Additional File 2: Figure S4). Each gene was then ran-
domly assigned a value from this distribution, and any
heterozygous SNVs/Indels falling within that gene were
inserted with the corresponding reference allele propor-
tion. This process was repeated multiple times, generat-
ing many independent simulated datasets where the
ratio of reference to alternative alleles at each heterozy-
gous site was known (the ground truth) and could be
compared to mapped and normalized data. Alternative
distributions were also generated and tested, and in
each case the general results were similar to those re-
ported in the main text (see Additional File 2: Figure S4
and Additional File 3: Table S1).
Method comparisons
We compared our normalization approach to two com-
monly used methods: the filtering approach and map-
ping to two parental genomes. For the filtering approach
we removed heterozygous sites that fell into low mapp-
ability regions (CRG map score < 1), those that have
known biases using 1000 Genomes data when mapping
with either BWA or GEM [34] and sites that are in
known duplicated regions [35]. Following this, we recal-
culated the average reference allele proportion using the
remaining sites, and used this as the expected value
within a binomial test under the same criteria as out-
lined above. For the two parental genomes approach we
took the original SNV and Indel calls generated from ex-
ome sequencing data for the individual in question and
phased them with ShapeIT2 using the 1000G reference
panel. SNVs and Indels not on the reference panel were
assigned randomly to one of the two haplotypes. Paren-
tal genomes for the simulated individual were generated
using the vcf2diploid program within AlleleSeq [18] and
parental GTF files were created using the output files
and liftOver tool. We then mapped the simulated data
to both parental genomes using the same mapping tools
and filtering pipelines as outlined above for the original
data. Read pairs mapping uniquely to either of the par-
ental genomes were kept and the best match was found
for any read pairs mapping to both genomes, scoring the
read pairs with +1 per nucleotide match and −2 per
indel mismatch. In all cases, if significant ASE occurs at
a site in the ground truth data, true positives are
counted if the method also shows significant ASE, with
the allelic bias occuring in the same direction as the
ground truth.
Allele specific expression and phenotype data
Heterozygous sites were tested for ASE using the binomial
test with p < 0.005 if they had coverage > =12X and both
alleles were found to be present in RNA sequencing data.
In all cases, we consider overlapping segments of read
pairs only once using the software bamUtil and allele
counts were obtained using samtools 1.1, with no BAQ
correction and overlaps ignored. For real RNA sequencing
data, one individual was initially removed as an outlier for
the number of heterozygous sites covered by at least 20
non-overlapping sequencing reads (Additional File 2:
Figure S5).
To compare allele proportions for adjacent heterozy-
gous SNVs in genes with a single documented transcript
(as obtained from the Ensembl gene set v75), on a per
individual basis we collected heterozygous SNVs within
each gene, subtracted the reference allele proportion
from one if it was above 50 % (to account for unknown
phase), and then calculated the absolute difference
between each adjacent SNVs. To generate a null distri-
bution, random pairs were drawn from the same set of
heterozygous SNVs and compared as above.
To consider the relationship between ASE and life-
style traits, ASE events were identified by resampled
each heterozygous site without replacement to a depth
of 20X and then performing binomial tests with a re-
laxed p-value (P < 0.05). The proportion of sites under-
going ASE was then calculated by dividing the number
of ASE events by the number of heterozygous SNVs
that had at least 20X coverage on a per individual basis,
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thus controlling for the effects of sequence depth vari-
ation. Two individuals were outliers for the proportion
of sites undergoing ASE (Additional File 2: Figure S6)
and were removed from all analysis.
Additional files
Additional file 1: Pipelines and examples to implement the ASE
normalization software. (PDF 111 kb)
Additional file 2: Supplementary Figures and Tables. (DOCX 978 kb)
Additional file 3: Table S2 detailing the numbers of covered sites and
ASE events within RNA sequencing data from 93 individuals. (XLSX 45 kb)
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